BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35066290)

  • 1. An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage.
    Zhang N; Zhang Y; Miao W; Shi C; Chen Z; Wu B; Zou Y; Ma Q; You S; Lu S; Huang X; Liu J; Xu J; Cao L; Sun Y
    Redox Biol; 2022 Apr; 50():102238. PubMed ID: 35066290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury.
    Zhang N; Zhang Y; Wu B; Wu S; You S; Lu S; Liu J; Huang X; Xu J; Cao L; Sun Y
    Redox Biol; 2021 Nov; 47():102141. PubMed ID: 34555594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling.
    Zhang N; Zhang Y; Qian H; Wu S; Cao L; Sun Y
    Cell Death Differ; 2020 Sep; 27(9):2605-2619. PubMed ID: 32139900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of WW domain E3 ubiquitin protein ligase 2 in modulating ubiquitination and Degradation of Septin4 in oxidative stress endothelial injury.
    Zhang N; Zhang Y; Wu B; You S; Sun Y
    Redox Biol; 2020 Feb; 30():101419. PubMed ID: 31924572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity.
    Chen Y; Yang LN; Cheng L; Tu S; Guo SJ; Le HY; Xiong Q; Mo R; Li CY; Jeong JS; Jiang L; Blackshaw S; Bi LJ; Zhu H; Tao SC; Ge F
    Mol Cell Proteomics; 2013 Oct; 12(10):2804-19. PubMed ID: 23824909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 ubiquitin ligase Smurf2 regulates PARP1 stability to alleviate oxidative stress-induced injury in human umbilical vein endothelial cells.
    Qian H; Zhang N; Wu B; Wu S; You S; Zhang Y; Sun Y
    J Cell Mol Med; 2020 Apr; 24(8):4600-4611. PubMed ID: 32167680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone-Assisted Mitotic Actin Remodeling by BAG3 and HSPB8 Involves the Deacetylase HDAC6 and Its Substrate Cortactin.
    Luthold C; Varlet AA; Lambert H; Bordeleau F; Lavoie JN
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
    Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
    Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMURF2-mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells.
    Ilić N; Tao Y; Boutros-Suleiman S; Kadali VN; Emanuelli A; Levy-Cohen G; Blank M
    FASEB J; 2021 Apr; 35(4):e21436. PubMed ID: 33734501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A.
    Yin Z; You S; Zhang S; Zhang L; Wu B; Huang X; Lu S; Cao L; Zhang Y; Li D; Zhang X; Liu J; Sun Y; Zhang N
    Biomed Pharmacother; 2023 Oct; 166():115228. PubMed ID: 37557013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of WWP2 aggravates Type 2 diabetes mellitus-induced vascular endothelial injury through modulating ubiquitination and degradation of DDX3X.
    You S; Xu J; Yin Z; Wu B; Wang P; Hao M; Cheng C; Liu M; Zhao Y; Jia P; Jiang H; Li D; Cao L; Zhang X; Zhang Y; Sun Y; Zhang N
    Cardiovasc Diabetol; 2023 May; 22(1):107. PubMed ID: 37149668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
    Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
    FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septin4 as a novel binding partner of PARP1 contributes to oxidative stress induced human umbilical vein endothelial cells injure.
    Zhang N; Zhang Y; Zhao S; Sun Y
    Biochem Biophys Res Commun; 2018 Feb; 496(2):621-627. PubMed ID: 29366480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress.
    Hishiya A; Kitazawa T; Takayama S
    Circ Res; 2010 Nov; 107(10):1220-31. PubMed ID: 20884878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency.
    Guilbert SM; Lambert H; Rodrigue MA; Fuchs M; Landry J; Lavoie JN
    FASEB J; 2018 Jul; 32(7):3518-3535. PubMed ID: 29405094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P209L mutation in Bag3 does not cause cardiomyopathy in mice.
    Fang X; Bogomolovas J; Zhou PS; Mu Y; Ma X; Chen Z; Zhang L; Zhu M; Veevers J; Ouyang K; Chen J
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H392-H399. PubMed ID: 30499714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.